CJC-1295 No DAC, also known as Modified GRF (1-29), is a synthetic analog of growth hormone-releasing hormone (GHRH). It consists of 29 amino acids and is designed to provide researchers with a stable model for investigating GHRH receptor activity and growth hormone signaling.

CJC-1295 No DAC differs from CJC-1295 with DAC because it does not contain the Drug Affinity Complex (DAC). As a result, it has a comparatively shorter duration of activity, making it particularly useful for laboratory studies examining transient or pulsatile growth hormone signaling.

The peptide is primarily investigated in research involving the GHRH receptor, pituitary growth hormone secretion, somatotropic-axis activity, and IGF-1-related signaling.

CJC-1295 No DAC Structure

Molecular Formula: C₁₅₂H₂₅₂N₄₄O₄₂
Molecular Weight: 3,367.9 g/mol
CAS Number: 863288-34-0

Amino Acid Sequence:
Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH₂

CJC-1295 No DAC incorporates several structural modifications designed to improve peptide stability compared with the native GHRH (1-29) sequence. These modifications provide researchers with a defined synthetic model for studying receptor binding, peptide stability, and downstream endocrine signaling.

Mechanism of Research Interest

CJC-1295 No DAC is studied primarily for its interaction with GHRH receptors located on pituitary somatotroph cells. Activation of these receptors is associated with intracellular signaling pathways involved in growth hormone secretion.

Research involving this peptide can examine:

• GHRH receptor activation

• Growth hormone secretion

• Pituitary signaling

• Somatotropic-axis regulation

• IGF-1-related pathways

• Pulsatile hormone signaling

• Peptide-receptor interactions

• Endocrine feedback mechanisms

Its relatively short activity profile makes it particularly relevant to experimental protocols designed to investigate short-duration stimulation and naturally occurring hormone-pulse patterns.

Research Applications

Growth Hormone Research

CJC-1295 No DAC is commonly investigated as a laboratory model for studying growth hormone regulation. Researchers can use it to examine how modified GHRH analogs interact with pituitary receptors and influence downstream endocrine pathways.

Areas of study include:

• Growth hormone release

• Pituitary function

• GHRH signaling

• Hormonal feedback

• IGF-1 signaling

• Somatotropic-axis physiology

Peptide Stability Research

The modified structure of CJC-1295 No DAC also makes it useful for investigating how specific amino acid substitutions influence peptide stability and biological activity.

Research may examine:

• Enzymatic degradation

• Peptide stability

• Structure-activity relationships

• Receptor selectivity

• Molecular interactions

• Synthetic peptide design

Physical Properties

• Appearance: White to off-white lyophilized powder

• Purity: ≥99%

• Form: Lyophilized peptide

• Solubility: Suitable for laboratory reconstitution using compatible aqueous research solutions

• Research Classification: Synthetic GHRH analog

Storage and Handling

Lyophilized CJC-1295 No DAC should be stored according to established peptide laboratory protocols and protected from excessive heat, moisture, and direct light.

For optimal stability:

• Keep the peptide in a controlled environment.

• Minimize exposure to moisture.

• Protect from direct light.

• Avoid unnecessary temperature fluctuations.

• Follow validated laboratory procedures for reconstitution and storage.

• Minimize repeated freeze-thaw cycles where practical.

Key Research Features

• Synthetic Modified GRF (1-29) peptide

• 29-amino-acid GHRH analog

• Investigated for GHRH receptor activity

• Useful for growth hormone signaling research

• Relevant to pulsatile endocrine research

• Studied in IGF-1 and somatotropic-axis models

• Modified structure designed for improved stability

• Supplied as a lyophilized research compound

Research Disclaimer

CJC-1295 No DAC is an investigational research compound intended for qualified laboratory and scientific research. It is not intended for human consumption, therapeutic use, or veterinary applications. Research findings from laboratory and preclinical models should not be interpreted as established evidence of safety or efficacy in humans.

CJC-1295 No DAC, also known as Modified GRF (1-29), is a synthetic growth hormone-releasing hormone (GHRH) analog widely studied in endocrine research, growth hormone signaling, pituitary physiology, peptide-receptor interactions, and somatotropic-axis biology. Researchers investigate CJC-1295 No DAC because of its ability to provide a stable model for examining GHRH receptor activation while retaining a relatively short duration of activity compared to DAC-modified variants.

As interest in growth-hormone pathway research continues to expand, researchers frequently compare CJC-1295 No DAC suppliers based on purity, analytical testing, manufacturing standards, pricing, and supplier transparency.

This CJC-1295 No DAC Vendor Price Comparison Guide helps researchers evaluate suppliers using objective criteria including:

• Product Pricing

• Cost Per Milligram

• Product Purity

• Third-Party Testing

• Certificate of Analysis (COA)

• Vendor Reputation

• Customer Reviews

• Shipping Performance

• Product Availability

• Overall Value

Whether you're searching for the lowest-priced CJC-1295 No DAC supplier, the highest-purity research-grade material, or vendors offering comprehensive laboratory verification, this guide provides a framework for comparing research peptide suppliers.

Explore CJC-1295 No DAC Vendors by Criteria

Most Popular CJC-1295 No DAC Vendors

Compare suppliers frequently selected by endocrinology and peptide researchers.

Highest Reviewed Vendors

Discover peptide suppliers with strong customer satisfaction and positive marketplace reputations.

Lowest Price Vendors

Identify suppliers offering competitive pricing and attractive cost-per-milligram value.

Highest Purity Vendors

Review suppliers providing transparent purity verification and analytical testing.

Best Value Vendors

Compare pricing, documentation quality, testing standards, and customer support.

Fastest Shipping Vendors

Evaluate fulfillment speed, package handling, and shipping reliability.

Newly Listed Vendors

Explore recently added suppliers offering CJC-1295 No DAC research peptides.

What Is CJC-1295 No DAC?

Overview

CJC-1295 No DAC is a synthetic analog of growth hormone-releasing hormone (GHRH) designed to improve peptide stability while maintaining a comparatively short activity profile.

Researchers investigate CJC-1295 No DAC because of its relationship with:

• GHRH receptor activity

• Growth hormone signaling

• Pituitary physiology

• Somatotropic-axis regulation

• Endocrine communication

• IGF-1 pathway research

• Hormonal feedback systems

• Peptide-receptor interactions

It is widely used as a research tool for studying pulsatile endocrine signaling.

Molecular Characteristics

Peptide Information

Researchers evaluating CJC-1295 No DAC products should carefully review analytical documentation and molecular specifications.

Peptide Name

CJC-1295 No DAC

Alternative Name

Modified GRF (1-29)

Classification

Synthetic GHRH Analog

Research Category

Growth Hormone & Endocrine Research

Molecular Formula

C₁₅₂H₂₅₂N₄₄O₄₂

Molecular Weight

3,367.9 g/mol

CAS Number

863288-34-0

Amino Acid Sequence

Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH₂

Typical Purity

≥99%

Product Format

White to Off-White Lyophilized Powder

Why Researchers Study CJC-1295 No DAC

CJC-1295 No DAC has generated significant interest because of its value as a model for investigating growth hormone regulatory pathways.

Researchers investigate pathways involving:

• Pituitary signaling

• GHRH receptor activation

• Hormonal communication

• Endocrine feedback loops

• IGF-1-related signaling

• Peptide stability

Its shorter duration of activity makes it particularly useful for studying transient hormone signaling events.

Mechanism of Research Interest

GHRH Receptor Research

One of the primary focuses of CJC-1295 No DAC research involves GHRH receptor activity.

Researchers investigate:

• Receptor activation

• Signal transduction

• Cellular communication

• Hormone secretion pathways

• Endocrine regulation

These studies remain central to understanding growth hormone physiology.

Pituitary Function Research

Scientists continue examining pathways involving:

• Somatotroph-cell activity

• Growth hormone signaling

• Hormone pulse generation

• Endocrine regulation

• Feedback control systems

Further investigations remain ongoing.

CJC-1295 No DAC & Growth Hormone Research

Growth Hormone Signaling

One of the most common applications of CJC-1295 No DAC involves studying growth hormone pathways.

Researchers investigate:

• Growth hormone release

• Signal amplification

• Endocrine communication

• Receptor responsiveness

• Cellular adaptation

This remains a core area of scientific investigation.

Somatotropic Axis Research

Research continues examining pathways involving:

• Growth hormone regulation

• IGF-1 signaling

• Hypothalamic-pituitary communication

• Endocrine balance

• Hormonal feedback systems

Additional studies continue to expand understanding in this area.

Key Areas of CJC-1295 No DAC Research

IGF-1 Pathway Research

Researchers investigate pathways involving:

• Growth-factor signaling

• Cellular communication

• Endocrine physiology

• Hormonal regulation

• Metabolic signaling

These remain important areas of study.

Pulsatile Hormone Signaling Research

Because of its shorter activity profile, CJC-1295 No DAC is frequently investigated in studies involving:

• Hormone pulses

• Endocrine timing

• Signal duration

• Receptor responsiveness

• Physiological hormone patterns

This is one of the primary distinctions between No DAC and DAC-modified variants.

Endocrine Feedback Research

Researchers continue studying pathways involving:

• Negative-feedback loops

• Hormonal communication

• Pituitary regulation

• Signal adaptation

• Endocrine homeostasis

Further investigation remains active.

Receptor-Binding Research

Scientists examine relationships involving:

• Ligand-receptor interactions

• Molecular selectivity

• Receptor affinity

• Cellular signaling

• Synthetic peptide design

These studies contribute to broader peptide-development research.

Peptide Stability Research

The modified structure of CJC-1295 No DAC remains an important area of investigation.

Researchers evaluate:

• Enzymatic resistance

• Molecular stability

• Degradation pathways

• Structure-activity relationships

• Synthetic peptide optimization

Additional research continues in this field.

Physical Properties

Appearance

White to Off-White Lyophilized Powder

Purity

≥99%

Solubility

Suitable for laboratory reconstitution with compatible aqueous research solutions.

Classification

Synthetic Modified GRF (1-29) Analog

Research Use

Growth Hormone & Endocrine Signaling Research

Storage & Handling

Researchers should follow established peptide laboratory protocols.

Best practices include:

✅ Protect from excessive heat

✅ Minimize moisture exposure

✅ Avoid unnecessary temperature fluctuations

✅ Protect from direct light

✅ Follow validated laboratory reconstitution procedures

✅ Minimize repeated freeze-thaw cycles

Proper storage practices help preserve peptide stability and consistency.

Why Researchers Compare CJC-1295 No DAC Vendors

Research reproducibility depends heavily on peptide quality and manufacturing consistency.

Differences among suppliers may include:

• Product purity

• Stability verification

• Batch consistency

• Manufacturing standards

• Analytical validation

• Storage procedures

• Documentation quality

• Quality-control systems

Careful supplier selection can improve consistency and reliability across studies.

How We Compare CJC-1295 No DAC Vendors

Third-Party Laboratory Testing

Independent testing remains one of the strongest indicators of peptide quality.

Researchers should prioritize suppliers offering:

• Third-party analytical testing

• Identity verification

• Purity confirmation

• Batch-specific reports

Certificate of Analysis (COA)

A quality COA should contain:

• Batch number

• Testing date

• Purity percentage

• Identity verification

• Analytical methodology

Product Purity

Purity remains one of the most important variables when evaluating research peptides.

Higher-purity materials generally promote improved reproducibility and experimental consistency.

Cost Per Milligram

Comparing vial prices alone may not accurately reflect overall value.

Cost Per Milligram Formula

Product Price ÷ Total Milligrams = Cost Per Milligram

This metric helps standardize supplier comparisons.

Customer Reviews

Customer experiences often provide insight regarding:

• Product consistency

• Shipping performance

• Packaging quality

• Customer support

• Purchasing experience

Vendor Reputation

Established suppliers often demonstrate:

• Transparent quality standards

• Reliable testing procedures

• Strong customer satisfaction

• Consistent inventory availability

Product Quality & Analytical Testing

Why Testing Matters

Research-grade CJC-1295 No DAC products should undergo testing to verify:

• Identity

• Purity

• Stability

• Composition

• Batch consistency

Common Testing Methods

High-Performance Liquid Chromatography (HPLC)

Used to evaluate purity and identify impurities.

Mass Spectrometry (MS)

Used to verify molecular identity and composition.

Identity Verification Testing

Confirms peptide authenticity.

Stability Testing

Evaluates peptide integrity during storage.

Batch Consistency Testing

Measures reproducibility across manufacturing lots.

Understanding CJC-1295 No DAC Pricing

Several factors influence supplier pricing.

Product Purity

Higher-purity products generally command premium pricing.

Complex Manufacturing

Long-chain synthetic peptides require advanced synthesis and purification techniques.

Analytical Verification

Comprehensive testing improves transparency while increasing production costs.

Research Demand

Growing interest in endocrine and growth-hormone research contributes to demand.

Vendor Reputation

Trusted suppliers often command higher prices due to rigorous quality-assurance practices.

CJC-1295 No DAC Vendor Evaluation Checklist

Quality Verification

✅ Third-party testing available

✅ Certificate of Analysis provided

✅ Identity verification documented

✅ Purity information disclosed

✅ Batch-specific testing available

✅ Stability information available

Vendor Reliability

✅ Positive customer reviews

✅ Transparent company information

✅ Responsive customer support

✅ Reliable inventory availability

Purchasing Experience

✅ Secure checkout process

✅ Shipment tracking available

✅ Clear refund policies

✅ Reliable order fulfillment

Frequently Asked Questions

What is CJC-1295 No DAC?

CJC-1295 No DAC is a synthetic Modified GRF (1-29) peptide designed for research involving growth hormone-releasing hormone receptors and endocrine signaling pathways.

What is CJC-1295 No DAC used for in research?

Researchers investigate CJC-1295 No DAC in studies involving growth hormone secretion, pituitary physiology, GHRH receptor activation, IGF-1 pathways, pulsatile hormone signaling, and endocrine feedback mechanisms.

How is CJC-1295 No DAC different from CJC-1295 with DAC?

The No DAC version does not contain the Drug Affinity Complex (DAC), resulting in a shorter duration of activity that makes it useful for studying transient or pulsatile hormone signaling.

Why compare vendors?

Purity, analytical testing, supplier reliability, and documentation quality can vary considerably among research peptide suppliers.

What should researchers review before purchasing?

Researchers should evaluate:

• Certificate of Analysis (COA)

• Third-party testing

• Purity verification

• Identity confirmation

• Vendor reputation

• Customer reviews

Final Thoughts

CJC-1295 No DAC remains one of the most widely studied synthetic GHRH analogs because of its usefulness in investigating growth hormone physiology, pituitary signaling, endocrine regulation, receptor-binding dynamics, and IGF-1-related pathways. Its relatively short activity profile makes it particularly valuable for researchers interested in natural hormone-pulse models and transient endocrine signaling.

When comparing CJC-1295 No DAC vendors, researchers should prioritize purity verification, third-party analytical testing, Certificate of Analysis availability, supplier reputation, and overall value rather than focusing exclusively on price. A structured vendor-comparison process can help identify suppliers capable of meeting rigorous research-quality standards.